FlexQube (FLEXQ) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
6 Aug, 2025Executive summary
Net sales for Q2 2025 decreased by 10.6% year-over-year to 22.3 MSEK, with order intake down 33.9% to 27.7 MSEK; both metrics improved sequentially from Q1 2025.
EBITDA improved to -8.5 MSEK from -11.1 MSEK year-over-year, reflecting cost reductions and higher gross margin above 50%.
Largest North American order to date (8.5 MSEK) for tugger train concept secured; first AMR project installed in Mexico.
Cash and cash equivalents at period end were 19.3 MSEK, down from 40.7 MSEK a year earlier.
Board repurchased and cancelled 220,000 options from former CEO, reducing dilution by 1.6%.
Financial highlights
Order intake for Q2 2025: 27.7 MSEK (down 33.9% year-over-year); net sales: 22.3 MSEK (down 10.6%).
EBITDA: -8.5 MSEK (improved from -11.1 MSEK); EBIT: -10.7 MSEK (improved from -13.4 MSEK).
Net loss for Q2: -11.4 MSEK (vs. -13.9 MSEK); EPS: -0.8 SEK (vs. -1.0 SEK).
Cash flow for Q2: -0.7 MSEK (vs. -3.4 MSEK); cash from operations: -1.2 MSEK.
Gross profit for Q2: 10.8 MSEK (vs. 11.8 MSEK); operating margin: -48.1% (vs. -53.8%).
Outlook and guidance
Order intake and sales in June reached break-even levels; sequential improvement in order intake by 28.9% over Q1.
Significant upside expected if AMR sales accelerate; break-even sales level estimated at 40 MSEK per quarter.
Large pilot project in the U.S. could lead to orders exceeding USD 12 million over 12–18 months if successful.
Focused marketing and sales resources on U.S. market for AMR and tugger train products.
Optimism for reduced market uncertainty and potential for increased automation demand due to labor shortages.
Latest events from FlexQube
- Q4 order intake surged 103% as robotics demand grew, despite lower sales and continued losses.FLEXQ
Q4 202511 Feb 2026 - Q3 order intake up 40.5% year-over-year, U.S. demand strong; net sales down 30.9%.FLEXQ
Q3 202511 Nov 2025 - Q3 2024 saw strong sales growth, improved margins, and major AMR orders in new markets.FLEXQ
Q3 202413 Jun 2025 - Order intake surged 121% but sales fell; cost cuts and AMR growth drive optimism for H2 2024.FLEXQ
Q2 202413 Jun 2025 - Gross margin and EBITDA improved despite lower sales, with a growing project pipeline.FLEXQ
Q1 20256 Jun 2025 - Q4 sales surged 41%, with positive EBITDA and cash flow, setting a strong base for 2025.FLEXQ
Q4 20245 Jun 2025